In a groundbreaking move for medical technology, China has officially become the first nation to authorize a commercially available brain-implant for treating disabilities. The device, known as NEO and developed by Neuracle Medical Technology, is specifically designed to translate the thoughts of paralyzed individuals into physical movements via an assistive robotic hand. Following 18 months of rigorous safety testing with 32 participants, the National Medical Products Administration approved the coin-sized implant for patients aged 19 to 60 suffering from severe spinal cord or neck injuries.
China approves world’s first commercial BCI device to help paralysis patients regain hand grasping ability. https://t.co/lgkdLM5Q57 pic.twitter.com/V4OcXqImwb
— Interesting Engineering (@IntEngineering) March 14, 2026
The NEO system utilizes eight electrodes placed on the brain’s movement-processing center to capture signals when a user imagines moving their hand. These signals are then processed by a computer and sent to a mechanical glove, allowing users to perform essential tasks like picking up objects or using utensils. This commercial milestone places China ahead of Western competitors like Neuralink, which are still navigating the clinical trial phase. Beyond medical recovery, Beijing has unveiled a 17-step strategic plan to dominate the brain-computer interface (BCI) industry within five years, aiming to integrate non-invasive devices into high-risk sectors such as nuclear energy and mining to enhance human performance and safety.
You May Like To Read: Federal Arts Panel Approves Trump Commemorative Gold Coin
Check out our latest video:
